Results 191 to 200 of about 1,363,468 (396)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Exploring the effectiveness of proactive service models in preventing medical disputes and petitions: a pilot investigation using a before-and-after design at a single center in Hangzhou, China. [PDF]

Front Public Health
Yang Y, Zhang Z, Chen S, Liu X, Zheng L, Huang S, Lu Y.   +6 more
europepmc   +1 more source

Agricultural Trade, Agreements, and Disputes in the Western Hemisphere

, 1989
Nicole Ballenger, Kathleen Doering, Mary C. Mervenne, Ballenger, Nicole, Doering, Kathleen, Mervenne, Mary C.   +5 more
openalex   +1 more source

Dispute Settlement in the Belt and Road Initiative: Progress, Issues, and Future Research Agenda [PDF]

, 2020
Jiangyu Wang
openalex   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Risk factors and management of medical disputes: An analysis of preliminary appraisal reports. [PDF]

PLoS One
Chang CT, Liaw YP.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Characteristics of exonerated cases of child sexual abuse. [PDF]

Front Psychol
Denne E, Sullivan CE, Neal TMS.
europepmc   +1 more source

European Neighbourhood Policy in the Function of International Dispute Settlement

, 2015
Jonida Mehmetaj
openalex   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source